医学
易普利姆玛
肿瘤浸润淋巴细胞
黑色素瘤
肿瘤科
免疫学
免疫疗法
免疫系统
癌症研究
作者
Maartje W. Rohaan,Troels Holz Borch,Joost H. van den Berg,Özcan Met,Rob Kessels,Marnix H. Geukes Foppen,Joachim Stoltenborg Granhøj,Bastiaan Nuijen,Cynthia M. Nijenhuis,Inge Jedema,Maaike van Zon,Saskia Scheij,Jos H. Beijnen,Marten Hansen,Carlijn Voermans,I.M. Noringriis,Tine J. Monberg,Rikke Boedker Holmstroem,Lidwina D.V. Wever,M. van Dijk
标识
DOI:10.1056/nejmoa2210233
摘要
In patients with advanced melanoma, progression-free survival was significantly longer among those who received TIL therapy than among those who received ipilimumab. (Funded by the Dutch Cancer Society and others; ClinicalTrials.gov number, NCT02278887.).
科研通智能强力驱动
Strongly Powered by AbleSci AI